Nel, ASAs

Nel ASA's Liquidity Buffer Faces Dual Test from Revenue and Write-Downs

21.04.2026 - 12:52:08 | boerse-global.de

Nel's Q1 2026 report is a crucial test of its ability to turn a surging order book into revenue, while facing potential write-downs at its Herøya site.

Nel ASA's Liquidity Buffer Faces Dual Test from Revenue and Write-Downs - Foto: über boerse-global.de
Nel ASA's Liquidity Buffer Faces Dual Test from Revenue and Write-Downs - Foto: über boerse-global.de

Investors in Norwegian hydrogen specialist Nel ASA are bracing for a pivotal financial update. The company reports its first-quarter 2026 results on Wednesday morning, with the spotlight fixed on its ability to convert a booming order book into revenue and the potential for significant asset impairments. The stock, having climbed roughly 21% since the start of the year to trade near 0.23 euros, faces a reality check.

The core challenge is a stark divergence between orders and sales. In the final quarter of 2025, order intake skyrocketed by 364% to 686 million Norwegian kroner (NOK), fueled by a major PEM electrolyzer contract. Paradoxically, revenue from customer contracts in the same period fell by 20%. For the full year 2025, revenue declined by 31%. Management has attributed this gap to irregular delivery schedules for large projects, making the Q1 figures a critical indicator of whether this trend is reversing.

Adding immediate pressure is a looming review of the company's Herøya production site. Nel is currently evaluating the future of two idled 500-megawatt production lines for atmospheric alkaline electrolyzers, considering reactivation, permanent closure, or sale. This evaluation carries a tangible risk of non-cash write-downs in the upcoming report. Such a move would further strain finances after a difficult 2025, which concluded with a net loss of 1.27 billion NOK following roughly 799 million NOK in impairments on production assets and intangible values.

Should investors sell immediately? Or is it worth buying Nel ASA?

Despite these headwinds, the company maintains a solid liquidity position of approximately 1.6 billion NOK. This buffer must now withstand potential Herøya-related charges while funding future growth. A key part of that growth strategy is the planned commercial launch of its new "Next Generation Pressurized Alkaline" system in the first half of 2026. The platform promises manufacturing costs up to 60% lower than current models. The European Union has pledged grants of up to 135 million euros, covering a significant portion of the investment for a planned 4-gigawatt annual capacity, with mass delivery targeted from 2027.

Ahead of the report, analyst sentiment remains cautious. Morgan Stanley slashed its price target to 2.00 NOK, while Citi reduced its fair value estimate to 2.40 NOK, both maintaining "Hold" ratings. Internally, the executive team has overhauled its compensation structure. A new Performance-Share-Unit program with clear, long-term performance criteria has replaced the previous stock option plan. CEO Håkon Volldal voluntarily relinquished his 1.5 million options and now holds approximately 3.5 million PSUs, aligning management incentives more closely with shareholder outcomes.

The virtual presentation at 08:00 CET on Wednesday will be the first practical test under this new regime. With an order backlog of 1.3 billion NOK and a recent operating EBITDA loss of 36 million NOK, the market demands clear signals that revenue conversion is accelerating. The half-year report, due on July 15, 2026, will provide the next checkpoint, but the immediate focus is on whether tomorrow's numbers can justify the stock's recent advance and provide a sustainable path forward.

Ad

Nel ASA Stock: New Analysis - 21 April

Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nel ASA analysis...

So schätzen die Börsenprofis Nel Aktien ein!

<b>So schätzen die Börsenprofis  Nel Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | NO0010081235 | NEL | boerse | 69228877 |